Programmed death (PD)-1 non-small cell lung cancer market to reach $41.45 billion by 2030 at 8.5% CAGR, driven by increasing adoption of personalized treatments.
Read More
Progesterone market to reach $3.54 billion by 2030 at 14.5% CAGR, driven by increasing prevalence of hormonal disorders.
Read More
Process analytical technology market to reach $5.4 billion by 2030 at 9.8% CAGR, driven by rising demand for personalized medicine.
Read More
Primary progressive multiple sclerosis treatment market to reach $2.18 billion by 2030 at 13.5% cagr, driven by growing demand for effective treatments for chronic & complex neurological conditions.
Read More
Primary myelofibrosis market to reach $1.14 billion by 2030 at 6.2% cagr, driven by increasing prevalence of myelofibrosis due to aging populations.
Read More
Primary cell culture market to reach $14.54 billion by 2030 at 13.1% cagr, driven by increasing prevalence of chronic diseases and rising demand for advanced research models.
Read More
Primary biliary cholangitis therapeutics market to reach $1.85 billion by 2030 at 12.9% cagr, driven by increasing prevalence of liver diseases associated with alcohol consumption.
Read More
Pre-workout vegan supplements market to reach $10.43 billion by 2030 at 13.1% cagr, driven by rising demand for plant-based products among health-conscious consumers.
Read More
Preventive vaccines market to reach $131.27 billion by 2030 at 9.8% cagr, driven by increasing prevalence of infectious diseases and rising focus on preventive healthcare.
Read More
Prescription pain medication market to reach $100.16 billion by 2030 at 5.3% cagr, driven by increasing prevalence of arthritis and chronic joint inflammation.
Read More